Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membranes in haemodialysis patients | Zendy

Ezio Movilli | Zendy; Giovanni Cancarini | Zendy; Roberta Zani | Zendy; Corrado Camerini | Zendy; Massimo Sandrini | Zendy; R Maiorca | Zendy

Open Access

Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membranes in haemodialysis patients

Author(s) -

Ezio Movilli,

Giovanni Cancarini,

Roberta Zani,

Corrado Camerini,

Massimo Sandrini,

R Maiorca

Publication year - 2001

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/16.1.111

Subject(s) - medicine , transferrin saturation , erythropoietin , gastroenterology , dialysis , iron deficiency , hemodialysis , ferritin , anemia , urology , surgery

The effect of the adequacy of dialysis on the response to recombinant human erythropoietin (rHuEpo) therapy is still incompletely understood because of many confounding factors such as iron deficiency, biocompatibility of dialysis membranes, and dialysis modality that can interfere.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research